AI & Biosecurity: Funding the Future of Health Threats!
In this presentation, the speaker outlines how emerging biotechnologies and artificial intelligence are reshaping biosecurity and health‑threat preparedness. The discussion highlights three technical pillars—on‑demand biologic manufacturing, field‑deployable testing with automated threat detection, and AI‑driven pathogen surveillance and antigen prediction. The speaker then maps these pillars onto current U.S. funding initiatives: NIH’s AVIDD centers supporting broad‑spectrum oral antivirals, BARDA’s Project NextGen advancing modular vaccine platforms, the Department of Defense’s M‑Tech program seeking rapid biomanufacturing and automated detection, and ARPA‑H’s recent call for AI tools to predict cross‑virus antigens and scale manufacturing. The overall message is that coordinated investment in these areas is essential to create flexible, rapid responses to future biological threats.
